Form 8-K - Current report:
SEC Accession No. 0001213900-25-032071
Filing Date
2025-04-15
Accepted
2025-04-15 16:05:09
Documents
14
Period of Report
2025-04-09
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0238051-8k_ostherapies.htm   iXBRL 8-K 47081
2 PRESS RELEASE, DATED APRIL 9, 2025 ea023805101ex99-1_ostherap.htm EX-99.1 15250
  Complete submission text file 0001213900-25-032071.txt   247177

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ostx-20250409.xsd EX-101.SCH 3023
4 XBRL LABEL FILE ostx-20250409_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE ostx-20250409_pre.xml EX-101.PRE 22364
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0238051-8k_ostherapies_htm.xml XML 3811
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 25839488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)